Skip to main content

Cyclopharm Health Care
Canada Cancer Healthcare Imaging

$2.00 0.07 (3.36%)

High

$2.02

Low

$1.95

Trades

7

Turnover

$14,184

Volume

7,103
30 June 2023 at 3:19pm
Register to track CYC and receive email alerts.
CYC Announcements on Price Chart

Latest Announcements

Headline Date
Notification of buy-back - CYC 16 May 2023 at 2:00pm
Results of Meeting 16 May 2023 at 1:59pm
Managing Director's Address to Shareholders 16 May 2023 at 11:50am
CYC 2023 AGM Presentation 16 May 2023 at 11:50am
Chairman's Address to Shareholders 16 May 2023 at 11:45am
Cyclopharm Confirms USFDA Scheduled Inspection Date 9 May 2023 at 8:40am
USFDA Confirms Technegas Six Month Review Period 24 April 2023 at 10:15am
Cyclopharm Acquires DuPharma ApS 20 April 2023 at 8:45am
Application for quotation of securities - CYC 18 April 2023 at 11:50am
Proposed issue of securities - CYC 17 April 2023 at 5:05pm
Notice of Annual General Meeting/Proxy Form 13 April 2023 at 12:10pm
Cyclopharm USFDA Approval Progress Update 5 April 2023 at 10:10am
Appendix 4G 31 March 2023 at 1:25pm
Annual Report to shareholders 31 March 2023 at 1:20pm
Technegas Enters Final Six Month USFDA Review Cycle 30 March 2023 at 11:20am
Application for quotation of securities - CYC 24 March 2023 at 12:05pm
Date of Annual General Meeting 15 March 2023 at 8:35am
CYC Results Summary 20 February 2023 at 2:45pm
Preliminary Final Report 20 February 2023 at 2:40pm
Dividend/Distribution - CYC 20 February 2023 at 2:30pm
Change of Director's Interest Notice - KBarrow 5 December 2022 at 8:45am
Change of Director's Interest Notice - DAngus 30 November 2022 at 4:35pm
Cyclopharm Receives $1.64m R&D Refund 29 November 2022 at 11:10am
Bell Potter Healthcare Conference Directors Profile 9 November 2022 at 9:55am
Bell Potter Healthcare Conference 9 November 2022 at 8:55am
Notification of cessation of securities - CYC 5 October 2022 at 4:30pm
CYC Board Changes 27 September 2022 at 9:35am
Initial Director's Interest Notice 27 September 2022 at 9:30am
Initial Director's Interest Notice 1 September 2022 at 8:20am
CYC Board Changes 1 September 2022 at 8:20am
Half Year 2022 Results 17 August 2022 at 8:40am
Half Yearly Report and Accounts 17 August 2022 at 8:35am
Dividend/Distribution - CYC 17 August 2022 at 8:35am
Technegas Used In Multicenter COVID Study 7 July 2022 at 9:15am
1H 2022 Business Update - Record Revenues 4 July 2022 at 10:55am
Change of Director's Interest Notice 14 June 2022 at 2:00pm
CYC Investor Presentation 24 May 2022 24 May 2022 at 10:05am
Technegas used in Diagnosing Long COVID 24 May 2022 at 9:20am
Change of Director's Interest Notice 23 May 2022 at 8:40am
Results of Meeting 17 May 2022 at 1:35pm
Managing Director's Address to Shareholders 17 May 2022 at 11:45am
CYC 2022 AGM Presentation 17 May 2022 at 11:40am
Chairman's Address to Shareholders 17 May 2022 at 11:35am
Notice of Annual General Meeting/Proxy Form 14 April 2022 at 10:30am
Appendix 4G 31 March 2022 at 2:30pm
Annual Report to shareholders 31 March 2022 at 2:30pm
Date of Annual General Meeting 16 March 2022 at 8:45am
Change of Director's Interest Notice 9 March 2022 at 3:10pm
S&P DJI Announces March 2022 Quarterly Rebalance 4 March 2022 at 5:30pm
CYC Results Summary 23 February 2022 at 7:05pm
Register to track CYC and receive email alerts.